Schwendicke Falk, Mertens Sarah, Cantu Anselmo Garcia, Chaurasia Akhilanand, Meyer-Lueckel Hendrik, Krois Joachim
Department of Oral Diagnostics, Digital Health and Health Services Research, Charité - Universitätsmedizin Berlin, Germany.
Department of Oral Diagnostics, Digital Health and Health Services Research, Charité - Universitätsmedizin Berlin, Germany.
J Dent. 2022 Apr;119:104080. doi: 10.1016/j.jdent.2022.104080. Epub 2022 Mar 1.
We assessed the cost-effectiveness of AI-supported detection of proximal caries in a randomized controlled clustered cross-over superiority trial.
Twenty-three dentists were sampled to assess 20 bitewings; 10 were randomly evaluated supported by an AI-based software (dentalXrai Pro 1.0.4, dentalXrai Ltd, Berlin, Germany) and the other 10 without AI support. The reference test had been established by four independent experts and an additional review. We evaluated the proportion of true and false positive and negative detections and the treatment decisions assigned to each detection (non-invasive, micro-invasive, invasive). Cost-effectiveness was assessed using a mixed public-private-payer perspective in German healthcare. Using the accuracy and treatment decision data from the trial, a Markov simulation model was populated and posterior permanent teeth in initially 31-years old individuals followed over their lifetime. The model allowed extrapolation from the initial detection and therapy to treatment success, re-treatments and, eventually, tooth loss and replacement, capturing long-term effectiveness (tooth retention) and costs (cumulative in Euro). Costs were estimated using the German public and private fee catalogues. Monte-Carlo microsimulations were used and incremental cost-effectiveness at different willingness-to-pay ceiling thresholds assessed.
In the trial, AI-supported detection was significantly more sensitive than detection without AI. However, in the AI group, lesions were more often treated invasively. As a result, AI and no AI showed identical effectiveness (tooth retention for a mean (2.5-97.5%) 49 (48-51) years) and nearly identical costs (AI: 330 (250-409) Euro, no AI: 330 (248-410) Euro). 41% simulations found AI and 43% no AI to be more cost-effective. The resulting cost-effectiveness remained uncertain regardless of a payer's willingness-to-pay.
Higher accuracy of AI did not lead to higher cost-effectiveness, as more invasive treatment approaches generated costs and diminished possible effectiveness advantages.
The cost-effectiveness of AI could be improved by supporting not only caries detection, but also subsequent management.
在一项随机对照整群交叉优势试验中,我们评估了人工智能支持的近端龋检测的成本效益。
抽取23名牙医评估20张咬合翼片;其中10张由基于人工智能的软件(dentalXrai Pro 1.0.4,德国柏林dentalXrai有限公司)支持进行随机评估,另外10张没有人工智能支持。参考测试由四位独立专家及一次额外审查确定。我们评估了真阳性和假阳性及阴性检测的比例,以及分配给每次检测的治疗决策(非侵入性、微侵入性、侵入性)。从德国医疗保健中公私合营支付方的综合角度评估成本效益。利用试验中的准确性和治疗决策数据,建立一个马尔可夫模拟模型,追踪最初31岁个体的恒牙一生情况。该模型允许从初始检测和治疗推断至治疗成功、再治疗,最终至牙齿脱落和修复,记录长期效果(牙齿保留)和成本(以欧元累计)。成本使用德国公共和私人收费目录估算。采用蒙特卡洛微观模拟,并评估不同支付意愿上限阈值下的增量成本效益。
在试验中,人工智能支持的检测比无人工智能支持的检测显著更敏感。然而,在人工智能组中,病变更常采用侵入性治疗。结果,有无人工智能显示出相同的效果(牙齿保留平均(2.5 - 97.5%)49(48 - 51)年)和几乎相同的成本(人工智能:330(250 - 409)欧元,无人工智能:330(248 - 410)欧元)。41%的模拟发现人工智能更具成本效益,43%的模拟发现无人工智能更具成本效益。无论支付方的支付意愿如何,由此产生的成本效益仍不确定。
人工智能更高的准确性并未带来更高的成本效益,因为更多的侵入性治疗方法产生了成本并削弱了可能的效果优势。
人工智能的成本效益可通过不仅支持龋齿检测,还支持后续管理来提高。